Brief: Quest Pharmatech Adopts Amendment To By-Laws Requiring Advance Notice Of Nomination Of Directors
20/12/2018 24:49
Dec 19 (Reuters) - Quest Pharmatech Inc QPT.V :
* QUEST PHARMATECH ADOPTS AMENDMENT TO BY-LAWS REQUIRING
ADVANCE
NOTICE OF NOMINATION OF DIRECTORS
* BY-LAW AMENDMENT IS EFFECTIVE IMMEDIATELY
Source text for Eikon: ID:nCNWkZwFHa
Further company coverage: QPT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quest PharmaTech
See all newsBrief: Quest Pharmatech Announces Change Of Chief Executive Officer
Brief: Quest Pharmatech Provides Product Development Update
Brief: Quest PharmaTech Clarifies Agreement in Principle with OQP Bio
Brief: Quest Pharmatech Provides Corporate Update
Brief: Quest PharmaTech Announces Sale Of Bioceltran Investment And Return Of Photodynamic Therapy Technology License